Case number 2017-1719
Endo Pharmaceuticals Solutions v. Custopharm Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | ENDO PHARMACEUTICALS SOLUTIONS v. CUSTOPHARM INC. [OPINION] [precedential] (0) |
| Aug 20, 2018 | 48 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [544017] [JAB] [Entered: 08/20/2018 12:15 PM] (1) |
| Jul 13, 2018 | 47 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (Precedential Opinion). (For the Court: Moore, Circuit Judge; Linn, Circuit Judge and Chen, Circuit Judge). [535615] [JAB] [Entered: 07/13/2018 09:08 AM] (24) |
| Mar 6, 2018 | 46 | Submitted after ORAL ARGUMENT by Mr. Douglass C. Hochstetler for Custopharm Inc. and Mr. Nevin M. Gewertz for Endo Pharmaceuticals Solutions, Inc., Bayer Pharma AG and Bayer Intellectual Property GmbH. Panel: Judge: Moore , Judge: Linn , Judge: Chen. [502809] [JCP] [Entered: 03/06/2018 10:52 AM] (0) |
| Jan 29, 2018 | 45 | Response to oral argument order from the Appellant Custopharm Inc.. designating Douglass C. Hochstetler as arguing attorney. Designated time for argument: 10 minutes. Designated time for rebuttal: 5 minutes. Service of other counsel by Notice of Docket Activity from this entry. [493393] [Mark Scott] [Entered: 01/29/2018 02:21 PM] (0) |
| Jan 26, 2018 | 44 | Response to oral argument order from the Appellees Bayer Intellectual Property GmbH, Bayer Pharma AG and Endo Pharmaceuticals Solutions, Inc.. designating Nevin M. Gewertz as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [493087] [Nevin Gewertz] [Entered: 01/26/2018 02:50 PM] (0) |
| Jan 22, 2018 | 43 | NOTICE OF CALENDARING. Panel: 1803F. Case scheduled Mar 06, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 203. Response to oral argument order due: 02/15/2018. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [491375] [JAB] [Entered: 01/22/2018 12:19 PM] (0) |
| Oct 24, 2017 | 42 | Notice from Appellees Bayer Intellectual Property GmbH, Bayer Pharma AG and Endo Pharmaceuticals Solutions, Inc. regarding conflicts with oral argument (January 8-12, 2018 and February 5-12, 2018). Service: 10/24/2017 by email. [470065] [Nevin Gewertz] [Entered: 10/24/2017 10:56 AM] (1) |
| Sep 15, 2017 | 41 | Notice from Appellant Custopharm Inc. regarding conflicts with oral argument (November 6-9, 2017). Service: 09/15/2017 by email. [461383] [Douglass Hochstetler] [Entered: 09/15/2017 02:37 PM] (2) |
| Sep 13, 2017 | 40 | Notice from Appellees Bayer Intellectual Property GmbH, Bayer Pharma AG and Endo Pharmaceuticals Solutions, Inc. regarding conflicts with oral argument (December 4-8, 2017). Service: 09/13/2017 by email. [460735] [Nevin Gewertz] [Entered: 09/13/2017 02:38 PM] (1) |
| Sep 12, 2017 | 39 | 6 paper copies of the Joint Appendix (Vols. I-III) [37] received from Appellant Custopharm Inc. and Appellees Bayer Intellectual Property GmbH, Bayer Pharma AG and Endo Pharmaceuticals Solutions, Inc. [460383] [CW] [Entered: 09/12/2017 12:19 PM] (0) |
| Sep 8, 2017 | 38 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 09/15/2017. [459798] [JB] [Entered: 09/08/2017 02:34 PM] (0) |
| Sep 7, 2017 | 37 | APPENDIX FILED for Custopharm Inc. and Bayer Intellectual Property GmbH, Bayer Pharma AG and Endo Pharmaceuticals Solutions, Inc. [35]. Number of Pages: 1247. Service: 09/07/2017 by email. The paper copies of the brief should be received by the court on or before 09/15/2017. [459794] [JB] [Entered: 09/08/2017 02:33 PM] (1247) |
| Sep 7, 2017 | 36 | Statement of Compliance with Fed. Cir. R. 33 for Appellant Custopharm Inc. and Appellees Bayer Intellectual Property GmbH, Bayer Pharma AG and Endo Pharmaceuticals Solutions, Inc.. Service: 09/07/2017 by email. [459436] [Douglass Hochstetler] [Entered: 09/07/2017 02:48 PM] (4) |
| Sep 7, 2017 | 35 | TENDERED from Appellant Custopharm Inc. and Appellees Bayer Intellectual Property GmbH, Bayer Pharma AG and Endo Pharmaceuticals Solutions, Inc.. Title: JOINT APPENDIX. Service: 09/07/2017 by email. [459431] [Douglass Hochstetler] [Entered: 09/07/2017 02:44 PM] (1247) |
| Sep 5, 2017 | 34 | 6 paper copies of the Reply Brief [33] received from Appellant Custopharm Inc. [458633] [CW] [Entered: 09/05/2017 02:41 PM] (0) |
| Aug 31, 2017 | 33 | REPLY BRIEF FILED for Appellant Custopharm Inc. [32]. Number of Pages: 28. Service: 08/31/2017 by email. The paper copies of the brief should be received by the court on or before 09/11/2017. Appendix is due 09/07/2017. [458310] [JB] [Entered: 09/01/2017 12:55 PM] (36) |
| Aug 31, 2017 | 32 | TENDERED from Appellant Custopharm Inc.. Title: REPLY BRIEF. Service: 08/31/2017 by email. [458112] [Douglass Hochstetler] [Entered: 08/31/2017 04:19 PM] (36) |
| Aug 3, 2017 | 31 | 6 paper copies of the Opening Response Brief [28] received from Appellees Bayer Intellectual Property GmbH, Bayer Pharma AG and Endo Pharmaceuticals Solutions, Inc.. [451320] [JB] [Entered: 08/03/2017 03:34 PM] (0) |
| Jul 31, 2017 | 30 | Clerk's Note to the File: Appellant's reply brief is due on 8/31/2017 per court order DE25 . [450366] [JB] [Entered: 07/31/2017 12:43 PM] (0) |
| Jul 31, 2017 | 29 | CLERK'S OFFICE MESSAGE: re: Brief [27], ERROR: Appellee used abbreviated page ranges when referring to the appendix (Ex. "Appx0172-76; Appx0671-72; Appx0387-88; Appx0608-10" on pg. 10). CORRECTION: When referring to a range of pages in the appendix, both the first and last number in the range must be listed in their entirety (for the example, the correct references would be "Appx0172-0176; Appx0671-0672; Appx0387-0388; Appx0608-0610"). For future briefs, please ensure all references are compliant. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [450336] [JB] [Entered: 07/31/2017 11:34 AM] (0) |
| Jul 27, 2017 | 28 | BRIEF FILED for Appellees Bayer Intellectual Property GmbH, Bayer Pharma AG and Endo Pharmaceuticals Solutions, Inc. [27]. Number of Pages: 55. Service: 07/27/2017 by email. The paper copies of the brief should be received by the court on or before 08/07/2017. Appellant Custopharm Inc. reply brief is due 08/10/2017. [450332] [JB] [Entered: 07/31/2017 11:27 AM] (65) |
| Jul 27, 2017 | 27 | TENDERED from Appellees Bayer Intellectual Property GmbH, Bayer Pharma AG and Endo Pharmaceuticals Solutions, Inc.. Title: RESPONSE BRIEF. Service: 07/27/2017 by email. [449814] [Nevin Gewertz] [Entered: 07/27/2017 05:00 PM] (65) |
| Jul 27, 2017 | 26 | Entry of appearance for Taylor A.R. Meehan as of counsel for Appellees Bayer Intellectual Property GmbH, Bayer Pharma AG and Endo Pharmaceuticals Solutions, Inc.. Service: 07/27/2017 by email. [449766] [Taylor Meehan] [Entered: 07/27/2017 03:50 PM] (2) |
| Jun 7, 2017 | 25 | ORDER filed. The motion [24] is granted. The appellees' response brief is due July 27, 2017 and the appellant's reply brief is due August 31, 2017. Service: 06/07/2017 by clerk. [436989] [LMS] [Entered: 06/07/2017 10:16 AM] (2) |
| Jun 2, 2017 | 24 | MOTION of Appellees Bayer Intellectual Property GmbH, Bayer Pharma AG and Endo Pharmaceuticals Solutions, Inc. to extend the time to 07/27/2017 to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 06/02/2017 by email. [435949] [Adam Mortara] [Entered: 06/02/2017 12:36 PM] (6) |
| May 4, 2017 | 23 | 6 paper copies of the Opening Brief [22] received from Appellant Custopharm Inc. [429138] [KW] [Entered: 05/04/2017 12:25 PM] (0) |
| May 2, 2017 | 21 | Entry of appearance for Sarita Mutha as of counsel for Appellant Custopharm Inc.. Service: 05/02/2017 by email. [428491] [Sarita Matheson] [Entered: 05/02/2017 12:50 PM] (3) |
| May 1, 2017 | 22 | BRIEF FILED for Appellant Custopharm Inc. [20]. Number of Pages: 62. Service: 05/01/2017 by email. The paper copies of the brief should be received by the court on or before 05/09/2017. Appellees Bayer Intellectual Property GmbH, Bayer Pharma AG and Endo Pharmaceuticals Solutions, Inc. brief is due 06/12/2017. [428610] [JB] [Entered: 05/02/2017 04:25 PM] (122) |
| May 1, 2017 | 20 | TENDERED from Appellant Custopharm Inc.. Title: OPENING BRIEF. Service: 05/01/2017 by email. [428333] [Douglass Hochstetler] [Entered: 05/01/2017 05:29 PM] (122) |
| Apr 13, 2017 | 19 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [423694] [JB] [Entered: 04/13/2017 08:44 AM] (0) |
| Mar 16, 2017 | 18 | Certificate of Interest for the Appellant Custopharm Inc.. Service: 03/16/2017 by email. [416382] [Douglass Hochstetler] [Entered: 03/16/2017 04:56 PM] (3) |
| Mar 16, 2017 | 17 | Docketing Statement for the Appellant Custopharm Inc.. Service: 03/16/2017 by email. [416381] [Douglass Hochstetler] [Entered: 03/16/2017 04:55 PM] (3) |
| Mar 16, 2017 | 16 | Entry of appearance for Faye E. Paul as of counsel for Appellees Bayer Intellectual Property GmbH, Bayer Pharma AG and Endo Pharmaceuticals Solutions, Inc.. Service: 03/16/2017 by email. [416084] [Faye Paul] [Entered: 03/16/2017 11:04 AM] (2) |
| Mar 16, 2017 | 15 | Entry of appearance for Nevin M. Gewertz as of counsel for Appellees Bayer Intellectual Property GmbH, Bayer Pharma AG and Endo Pharmaceuticals Solutions, Inc.. Service: 03/16/2017 by email. [416082] [Nevin Gewertz] [Entered: 03/16/2017 11:02 AM] (2) |
| Mar 16, 2017 | 14 | Entry of appearance for J. Scott McBride as of counsel for Appellees Bayer Intellectual Property GmbH, Bayer Pharma AG and Endo Pharmaceuticals Solutions, Inc.. Service: 03/16/2017 by email. [416075] [John McBride] [Entered: 03/16/2017 11:00 AM] (2) |
| Mar 16, 2017 | 13 | Docketing Statement for the Appellees Bayer Intellectual Property GmbH, Bayer Pharma AG and Endo Pharmaceuticals Solutions, Inc.. Service: 03/16/2017 by email. [416073] [Adam Mortara] [Entered: 03/16/2017 10:57 AM] (4) |
| Mar 16, 2017 | 12 | Certificate of Interest for the Appellees Bayer Intellectual Property GmbH, Bayer Pharma AG and Endo Pharmaceuticals Solutions, Inc.. Service: 03/16/2017 by email. [416067] [Adam Mortara] [Entered: 03/16/2017 10:54 AM] (2) |
| Mar 16, 2017 | 11 | Entry of appearance for Adam K. Mortara as principal counsel for Appellees Bayer Intellectual Property GmbH, Bayer Pharma AG and Endo Pharmaceuticals Solutions, Inc.. Service: 03/16/2017 by email. [416064] [Adam Mortara] [Entered: 03/16/2017 10:51 AM] (2) |
| Mar 15, 2017 | 10 | Corrected Entry of appearance for Mark Scott as of counsel for Appellant Custopharm Inc.. Service: 03/15/2017 by email. [415885] [Mark Scott] [Entered: 03/15/2017 05:09 PM] (2) |
| Mar 15, 2017 | 9 | Corrected Entry of appearance for Constantine Koutsoubas as of counsel for Appellant Custopharm Inc.. Service: 03/15/2017 by email. [415883] [Constantine Koutsoubas] [Entered: 03/15/2017 05:08 PM] (2) |
| Mar 15, 2017 | 8 | Corrected Entry of appearance for Clifford Katz as of counsel for Appellant Custopharm Inc.. Service: 03/15/2017 by email. [415881] [Clifford Katz] [Entered: 03/15/2017 05:06 PM] (2) |
| Mar 15, 2017 | 7 | Corrected Entry of appearance for Douglass C. Hochstetler as principal counsel for Appellant Custopharm Inc.. Service: 03/15/2017 by email. [415878] [Douglass Hochstetler] [Entered: 03/15/2017 05:04 PM] (2) |
| Mar 15, 2017 | 6 | NOTICE OF DEFICIENCY: The attorney entry of appearance Document No. [5] filed by Appellant Custopharm Inc., attorney entry of appearance Document No. [4] filed by Appellant Custopharm Inc., attorney entry of appearance Document No. [3] filed by Appellant Custopharm Inc., attorney entry of appearance Document No. [2] filed by Appellant Custopharm Inc., are without a proper/complete proof of service and are not text searchable (submitted as editable forms) and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [415768] [JB] [Entered: 03/15/2017 03:20 PM] (0) |
| Mar 15, 2017 | 5 | Entry of appearance for Mark Scott as of counsel for Appellant Custopharm Inc.. Service: 03/15/2017 by email. [415688] [Mark Scott] [Entered: 03/15/2017 12:52 PM] (0) |
| Mar 15, 2017 | 4 | Entry of appearance for Constantine Koutsoubas as of counsel for Appellant Custopharm Inc.. Service: 03/15/2017 by email. [415683] [Constantine Koutsoubas] [Entered: 03/15/2017 12:28 PM] (0) |
| Mar 15, 2017 | 3 | Entry of appearance for Douglass C. Hochstetler as principal counsel for Appellant Custopharm Inc.. Service: 03/15/2017 by email. [415681] [Douglass Hochstetler] [Entered: 03/15/2017 12:24 PM] (0) |
| Mar 15, 2017 | 2 | Entry of appearance for Clifford Katz as of counsel for Appellant Custopharm Inc.. Service: 03/15/2017 by email. [415680] [Clifford Katz] [Entered: 03/15/2017 12:21 PM] (0) |
| Mar 2, 2017 | 1 | Appeal docketed. Received: 03/01/2017. [411924]Entry of Appearance due 03/16/2017. Certificate of Interest is due on 03/16/2017. Docketing Statement due 03/16/2017. Appellant/Petitioner's brief is due 05/01/2017. [JB] [Entered: 03/02/2017 11:34 AM] (44) |
